参考文献/References:
［1］VANNUCCINI S, LUISI S, TOSTI C, et al. Role of medical therapy in the management of uterine adenomyosis ［J］. Fertility and Sterility, 2018, 109(3): 398-405.
［2］中华医学会妇产科学分会子宫内膜异位症协作组．子宫内膜异位症的诊治指南 ［J］．中华妇产科杂志，2015，50（3）：161-169．
［3］徐嘉宁，周应芳．子宫腺肌病痛经相关因素的研究进展 ［J］．中华妇产科杂志，2013，48（2）：144-147．
［4］周应芳．子宫腺肌病术前预处理及术后药物治疗 ［J］．妇产与遗传（电子版），2016，6（2）：3-5．
［5］周应芳．子宫腺肌病的非手术治疗 ［J］．中国医师杂志，2015，17（4）：491-493．
［6］复方口服避孕药临床应用中国专家共识专家组．复方口服避孕药临床应用中国专家共识 ［J］．中华妇产科杂志，2015，50（2）：81-91．
［7］SHAABAN O M, ALI M K, SABRA A M, et al. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial ［J］. Contraception, 2015, 92(4): 301-307.
［8］Bahamondes L， Bahamondes M V， Shulman L P . Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods ［J］. Human Reproduction Update, 2015, 21(5):640-651.
［9］程利南，狄文，丁岩，等．女性避孕方法临床应用的中国专家共识 ［J］．中华妇产科杂志，2018，53（7）：1-15．
［10］OLADOSU F A, TU F-f, HELLMAN K M. Nonsteroidal antiinflammatory drug resistance in dysmenorrhea:epidemiology,causes,and treatment ［J］. American Journal of Obstetrics and Gynecology, 2018, 218(4): 390-400.
［11］NAGATA C, YANAGIDA S, OKAMOTO A, et al. Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest ［J］. Journal of Obstetrics and Gynaecology Research, 2012, 38(4): 639-644.
［12］OSUGA Y, FUJIMOTO-OKABE H, HAGINO A. Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study ［J］. Fertility and Sterility, 2017, 108(4): 673-678.
［13］BADAWY A M, ELNASHAR A M, MOSBAH A A. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial ［J］. Acta Obstetricia et Gynecologica Scandinavica, 2012, 91(4): 489-495.
［14］WAN Lei, ZOU Yang, WAN Li-hui, et al. Tanshinone IIA inhibits the proliferation, migration and invasion of ectopic endometrial stromal cells of adenomyosis via 14-3-3 zeta down regulation ［J］. Archives of Gynecology and Obstetrics, 2015, 292(6): 1301-1309.
［15］SHANG Wen-qing, YU Jia-jun, ZHU Lei, et al. Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells ［J］. American Journal of Translational Research, 2015, 7(10): 1782-1797.
［16］周应芳. 子宫内膜异位症患者长期管理的必要性 ［J］. 中华妇产科杂志, 2017，52(3)：145-146.
［17］郎景和, 崔恒, 戴毅,等. 2015年子宫内膜异位症的诊治指南专家解读 ［J］. 中华妇产科杂志, 2017, 52(12):857-861.
［18］盛燕霞，马彩虹，杨蕊，等．不同控制促排卵方案对子宫腺肌病患者体外受精-胚胎移植结局的影响 ［J］．生殖与避孕，2010，30（6）：375-378．
［19］SALIM R, RIRIS S, SAAB W, et al. Adenomyosis reduces pregnancy rates in infertile women undergoing IVF ［J］. Reproductive BioMedicine Online, 2012, 25(3): 273-277.
相似文献/References:
[1]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[2]苏慧明,徐燕,黎颖雄,等.诺舒子宫内膜去除术治疗子宫腺肌病致月经过多的临床研究[J].中国计划生育和妇产科,2014,(03):0.
SU Hui-ming,XU Yan,LI Ying-xiong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(4):0.
[3]毛世华,谭晓燕,范玲,等.高强度聚焦超声联合米非司酮治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
MAO Shi-hua,TAN Xiao-yan,FAN Ling,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(4):0.
[4]邓淑珍.曼月乐宫内节育器治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
DENG Shu-zhen,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(4):0.
[5]王宇慧,魏绍斌.中成药治疗子宫内膜异位症和子宫腺肌病的辨证应用[J].中国计划生育和妇产科,2015,(02):0.
[6]邓云,丁惠,许永华,等.高强度聚焦超声治疗子宫腺肌病病灶消融率影响因素分析[J].中国计划生育和妇产科,2015,(06):0.
DENG Yun,DING Hui,XU Yong-hua,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(4):0.
[7]孙馥箐,段华,叶红,等.双子宫畸形伴双侧子宫腺肌病与左侧子宫肌瘤1例并文献复习[J].中国计划生育和妇产科,2016,(04):0.
[8]李金皎,段华,汪沙,等.子宫腺肌病患者子宫肌层平滑肌细胞生长状态与增殖特点的研究[J].中国计划生育和妇产科,2016,(05):0.
LI Jin-jiao,DUAN Hua,WANG Sha,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(4):0.
[9]李晓欣,张萍,张纯溪,等.促性腺激素释放激素激动剂联合腹腔镜手术治疗大子宫腺肌病疗效的研究[J].中国计划生育和妇产科,2016,(07):0.
LI Xiao-xin,Zhang Ping,Zhang Chun-xi,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(4):0.
[10]贾晨阳,段华,汪沙,等.血管形成相关因子在子宫腺肌病发病中作用的研究进展[J].中国计划生育和妇产科,2016,(08):0.
JIA Chen-yang,DUAN Hua,WANG Sha,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(4):0.